Indian shares muted on U.S. rate hike worries, pharma stocks slide

  • 📰 Reuters
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Indian shares struggled for direction on Monday on worries that the U.S. Federal Reserve would keep interest rates higher for longer.

"Inflation remains the number one risk to global markets although the markets do not seem to be pricing the risk adequately," said Pramod Gubbi, co-founder of Marcellus Investment Managers.

However, a revival in the capex cycle should aid economic recovery and contribute to the resilience of domestic equities, Gubbi added. Indian markets are likely to trade between 17,800 and 18,300 in the near term, two analysts said, adding that lingering concerns on Fed rate hikes and the likelihood of global growth slowdown would offset a potential upsurge due to attractive valuations.

Investors await the minutes of the Fed's meeting, due on Wednesday, to assess the U.S. central bank's future rate hiking path. U.S. markets will be closed on Monday for a local holiday. Reporting by Bharath Rajeswaran in Bengaluru; Editing by Nivedita Bhattacharjee and Dhanya Ann Thoppil

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Ukraine

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines